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Background. The aim of this study is to detect possible risk factors for development of short- and long-term local complications
after inguinofemoral lymphadenectomy for vulval cancer. Methods. This retrospective cohort study included 34 vulval cancer
patients that received inguinofemoral lymphadenectomy. The detected complications were wound cellulitis, wound seroma
formation, wound breakdown, wound infection, and limb lymphoedema. Followup of the patient ran up to 84 months after
surgery. Results. Within a total of 64 inguinofemoral lymphadenectomies, 24% of the inguinal wounds were aﬀected with cellulitis,
13% developed a seroma, 10% suﬀered wound breakdown, 5% showed lower limb edema within a month of the operation, and
21.4% showed lower limb edema during the long-term followup. No signiﬁcant correlation could be found between saphenous
vein ligation and the development of any of the local complications. The 3-year survival rate in our cohort was 89.3%. Conclusions.
Local complications after inguino-femoral lymphadenectomy are still very high, with no single pre-, intra-, or postoperative factor
thatcouldbeincriminated.Saphenousveinsparingprovidednosigniﬁcantdiﬀerenceindecreasingtherateoflocalcomplications.
More trials should be done to study the sentinel lymph node detection technique.
1.Introduction
Vulval cancer is the fourth most common gynecologic ma-
lignancy accounting for 5% to 8% of all female genital
tract malignancies [1]. The incidence of vulval cancer is on
the rise and may be due to the increased life expectancy
of the females in the developed societies [2]. Since the
en bloc dissection through a butterﬂy incision that was
advocated by Taussig in the 1940s [3], many modiﬁcations
were adopted in order to decrease the associated high
morbidity after such radical surgical procedure. Modifying
the surgical technique through using the triple groin incision
[4]insteadoftheoriginalenblocsurgicalresectionandusing
saphenous vein sparing technique [5] succeeded partially in
decreasing the high local morbidity associated with surgery
for inguinofemoral nodal clearance. Wound cellulitis occurs
in 25–39% of patients, wound breakdown in 17–31% of
patients, and lymphedema in 28–39% of patients [6–8].
Despite the decrease in the incidence of morbidities after
inguinofemoral lymph node clearance, the rate is still high.
Inguinofemoral lymph node clearance can be omitted in
vulval lesions smaller than 2cm with inﬁltration not deeper
than 1mm [1]. Contralateral lymphadenectomy can only be
omitted in small T1 unilateral lesions when the ipsilateral
lymph nodes are free, but it is standard if the lesion is 1cm
or less close to the midline [9]. The following study aims
at analyzing possible factors associated with development of
postoperative wound complications.
2. Patients andMethods
This retrospective cohort study was performed in the
Department of Gynaecology and Obstetrics, University of
Duisburg-Essen,Germany.Patients’recordswereanalysedin
the period between January 2002 to December 2009 looking
for patients with the diagnosis of invasive Vulval Cancer
that received a radical vulvectomy with inguinofemoral
lymphadenectomy. Microinvasive vulval cancer patients,
patients with relapse of vulval cancer, and patients with
advanced inguinal disease with palpable, ﬁxed, or ulcerated
inguinal lymph nodes were excluded from our analysis.
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Table 1: Frequency (n) of simultaneous complications in the same groin.
Wound cellulitis Wound breakdown Wound seroma formation Wound infection Early leg lymphedema
Wound cellulitis 5 (P<0.001) 3 1 1
Wound breakdown 5 (P<0.001) 1 0 0
Wound seroma formation 3 1 0 0
Wound infection 1 0 0 0
Early leg lymphedema 1 0 0 0
a separate skin incision between the anterior superior iliac
spineandthepubictubercle,paralleltotheinguinalligament
and with a length of about 7cm. All the lymphofatty tissue
extending from 2cm above the inguinal ligament to the
sartorius muscle laterally and the medial border of the
adductor longus medially are removed. These tissues are
removed along with the cribriform fascia and the lymphatic
tissues running along the femoral vessels and in between
them from just below the inguinal ligament till about 2cm
proximal to the beginning of Hunter’s canal when the
femoral vessels are crossed by the Sartorius muscle. In our
institution, the greater saphenous vein is spared whenever
possible. Closed suction drainage was universally used in all
the operated cases. Lymph drainage massage, compression
stockings, and subcutaneous antithrombosis prophylaxis are
standardtreatmentsapplied toallthepatients. Thefollowing
characteristics were registered: patient’s age, cardiovascular
diseases, diabetes mellitus, amount of intraoperative bleed-
ing, saphenous vein ligation, number of days of suction
drainage, the average daily and the total amount of ﬂuid
accumulated in the drains, TNM staging, number of lymph
nodes resected as well as the number of inﬁltrated lymph
nodes, development of wound cellulitis (local redness and
swelling of the wound edges with no evidence of infection),
wound seroma (accumulation of ﬂuid in the wound space
without opening the wound edges that can be detected
sonographically), wound breakdown (deﬁned as opening
of one-third or more of the wound length that requires
secondary sutures), wound infection (documented with bac-
teriological smear), and development of limb lymphedema.
The sites of relapse and the time to relapse from the date
of the operation are registered during the followup. Long-
term complications are also registered during the follow-
up period. The registered data was tabulated and analysed
using Chi square and Fischer exact tests for categorical
data. P values of less than 0.05 are considered statistically
signiﬁcant.
3. Results
Analyzing the operative records in the aforementioned time
period yielded 76 vulvalcancerpatients withonly34patients
that received radical inguinofemoral lymphadenectomy, 30
ofthemhadbilateralinguinofemorallymphadenectomy,and
4 patients had unilateral inguinofemoral lymphadenectomy
summing up into a total of 64 inguinal lymphadenectomy
procedures. The median age of our patients was 56.5 years
(range from 23 to 86 years). 31% of our cohort aged between
45 and 55, and 53% were 55 years of age or older. Age
was independent of the development of inguinal wound
complications. 37.5% (n = 12) of the cohort had heart
diseases: hypertension, coronary artery diseases, arrhythmia,
or valvular diseases. 20% of the patients (n = 7) had diabetes
mellitus. 73% (n = 47) of the operated groins had 7 or
more lymph nodes excised per groin, 44.5% (n = 28) had
10 or more lymph nodes excised; these numbers reﬂect the
radicality of the adopted surgical procedure. 31% of the
patients were stage T1b (TNM classiﬁcation) (n = 12), 65%
wereT2(n = 21)andonlyonepatienthadT3.Thefrequency
of development of inguinal wound complications was 24.2%
(n = 15) wound cellulitis, 9.7% (n = 6) wound breakdown,
12.5% (n = 8) wound seroma, and 3.2% (n = 2) wound
infection. 4.8% (n = 3) developed early limb lymphoedema
while on long-term followup 21.4% (n = 6) showed lower
limb lymphoedema. Many pre-, intra-, and post-operative
factors were investigated. Cardiac diseases and the amount
of intraoperative bleeding were both signiﬁcantly related to
the development of wound cellulitis (P = 0.022 and P =
0.026, resp.). Cardiac diseases were also signiﬁcantly related
to the development of wound breakdown (P = 0.001).
The number of inﬁltrated lymph nodes was signiﬁcantly
related to the development of wound seroma (P = 0.005).
Saphenous vein ligation carried no signiﬁcant correlation to
the development of any of the studied wound complications.
Thedurationofwoundsuctiondrainage,theamountofexu-
date accumulated in the drains, and the number of excised
lymph nodes per groin were not signiﬁcantly correlated
to the development of any of the studied complications.
Only one vulval wound was complicated with infection,
and another vulval wound was complicated with wound
dehiscence. Table 1 shows the frequency of simultaneous
occurrence of wound complications in the same groin in
our cohort. A signiﬁcant correlation was found between
the development of wound cellulitis and the subsequent
development of wound breakdown (P<0.001).
The patients were followed up after surgery for a median
period of 30 months (range from 6 to 84 months). 6 patients
were lost to follow up. 3 deaths due to cancer were registered,
and they were all pT2. Time interval to death due to cancer
ranged from 5 to 30 months with a median of 10.5 months.
1 Mortality was due to complications of cancer treatment,
while the other two were due to cancer recurrence. The 3-
year survival rate is 89.3%. Local recurrence was registered
in 17.8%(n = 5) of cases. The median time to recurrence
was 11 months (range from 6 to 38 months). No inguinal
recurrences were reported. Development of early wound
complications did not correlate to the development of long-
term limb-lymphoedema.The Scientiﬁc World Journal 3
Table 2: Comparison between the incidence of wound complications in the current cohort and other published data.
Current study Gaarenstroom et al. [7] Gould et al. [6]
Wound cellulitis 24.2% (n = 15) Not studied 35.4%
Wound breakdown 9.7% (n = 6) 11% (n = 21) 19.4%
Wound seroma 12.5% (n = 8) 27% (n = 50) 13.1%
Wound infection 3.2% (n = 2) 27% (n = 51) Not studied
Early lower limb lymphedema formation 4.8% (n = 3) 21% (n = 40) 4.8%
4. Discussion
Since the introduction of the radical vulvectomy and
bilateral inguinofemoral lymphadenectomy through the
butterﬂy skin incision by Taussig [3] in the 1940s, many
modiﬁcations were introduced to the operative technique
aiming at decreasing the reported high complications rate
without compromising the radicality of the procedure or
aﬀecting the survival and recurrence rates that is why the
triple incision procedure was introduced to replace the en
bloc surgical excision [4, 10]. Another modiﬁcation was
introduced when Zhang et al. published their retrospective
analysis comparing saphenous vein sparing to saphenous
vein ligation during the inguinal lymphadenectomy and its
impact on the development of complications. They found
signiﬁcant decrease in the development of short-term lower
limbphlebitisinthesaphenousveinsparedgroup;otherwise,
no signiﬁcant diﬀerences were noted between the two groups
as regards the development of post-operative wound seroma,
acute inguinal wound cellulitis, or lymphocyst formation
[11]. However, we proved in our study that saphenous
vein ligation did not signiﬁcantly aﬀect the development
of any of the studied postoperative complications including
limb lymphedema formation, even on long-term followup.
While Gould et al. found a signiﬁcant correlation between
the development of early wound complications and the
development of late complications like lymphedema [6],
Gaarenstroom and his group failed to ﬁnd any correlation
between early and late complications in their published
cohort [7]. In our study, development of inguinal wound
cellulitis was signiﬁcantly correlated to the subsequent devel-
opment of early wound breakdown. However, the incidence
of wound complications or early lymphedema was not
correlated to the development of leg lymphedema or any
other local complications in the long-term followup. The
relatively lower complications rates registered in our cohort
in comparison to other publications (see Table 2)m i g h tb e
explained but cannot be conﬁrmed, by the routine use of
compression stockings, daily wound cleansing, prophylactic
antibiotic intake, and daily lymph drainage massage.
The observation that the presence cardiac diseases was
signiﬁcantly correlated with the development of wound
cellulitis, and the subsequent development of wound break-
down could be explained but not validated by the possible
limited tissue perfusion in the presence of cardiovascular
disease with consequent aﬀection of the healing power
of the tissues. However, during our literature review, we
could not recognize any other author who mentioned this
observation studied or discussed it; thus, this point will
remain open for further research to validate it and possibly
explain its mechanism. The observation that the amount
of intraoperative bleeding was signiﬁcantly correlated with
the development of wound cellulitis was also not studied or
mentioned by other authors and remains open for further
validation and explanation. In our opinion, excessive intra-
operative bleeding invited more electrocoagulation of the
tissues or inserting hemostatic sutures, which will increase
tissue ischemia and hence healing power postoperatively, but
still this remains open for further discussion and validation.
In spite of the aforementioned modiﬁcations to the sur-
gical technique, the incidence of wound complications was
still high. This invited trying other additional materials and
techniques to decrease the high morbidity. One Gynecologic
Oncology Group study was designed to examine the eﬃcacy
of a commercially available FDA-approved ﬁbrin sealant-
applied to the inguinal wound compared to conventional
wound closure methods. However, the 137 patients included
in this study did not show any signiﬁcant diﬀerence in the
rate of development of leg lymphedema in any subgroup.
Theinguinalwoundcomplicationsratesdidnotsigniﬁcantly
diﬀer between both treatment modalities, and the devel-
opment of vulval wound infection was even signiﬁcantly
more frequent in the ﬁbrin sealant treatment arm [12]. The
successofthesentinellymphnodedetectiontechniqueinthe
treatment of breast cancer and melanomas made it possible
to study its results in vulval cancer patients. Since the ﬁrst
report of sentinel lymph node detection techniques in vulval
cancer by Levenback et al. using isosulfan blue dye [13],
many authors have tried to prove the eﬃcacy and accuracy
of such a conservative operative technique in dealing with
early stage cases. Almost all the reports focused on the
detection rates of aﬀected lymph nodes in comparison with
the current radical surgical methods, and they scrutinized
the false negative rates and methods to decrease them to an
acceptable minimum, but very few reports to date addressed
the eﬀect of such a technique in decreasing the high rate of
operative morbidity after standard radical inguinofemoral
lymphadenectomy [14–19]. Most of the authors report a
very low false negative detection rate ranging between 0%
and 9%, but Radziszewski et al. reported a low negative
predictive value of the sentinel lymph node procedure of
92% concluding that it is not possible to recommend it as
a standard procedure for treating early vulval cancer [19].
Van Der Zee et al. in the largest published prospective trial
to date studying the sentinel lymph node detection in early
vulval cancer reported an 11.7%, 4.5%, and 1.9% incidence4 The Scientiﬁc World Journal
of inguinal wound breakdown, inguinal wound cellulitis,
and leg lymphoedema, respectively, in the sentinel lymph
node only group. This was the biggest trial to analyze the
short- and long-term complications of sentinel lymph node-
detection technique. It showed a 97% 3-year survival with
2.3% groin recurrence rate and 12.3% local recurrence rate
for patients with negative sentinel lymph nodes [20]. It is,
therefore, clear from the above data that there is no single
risk factor that aﬀects the development of local inguinal
complications. It is also obvious that saphenous nerve
sparing techniques do not necessarily decrease the incidence
of local complications. Sentinel lymph node technique is
proved successful in decreasing the local complications rate,
but its sensitivity and speciﬁcity are still needed to be further
examined by means of well-designed randomized controlled
trials.
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